Focus on JNJ-Q2, a novel fluoroquinolone, for the management of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections

Jones TM, Johnson SW, DiMondi VP, Wilson DT

Infection and Drug Resistance 2016, 9:119-128

Published Date: 7 June 2016